Application Information

This drug has been submitted to the FDA under the reference 125319/001.

Names and composition

"ILARIS" is the commercial name of a drug composed of CANAKINUMAB.
It belongs to the class Biologics and is used in Rheumatoid arthritis, other autoimmune disorders (Musculoskeletal Disorders)

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
125319/001 ILARIS CANAKINUMAB INJECTABLE/ SUBCUTANEOUS 180MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
125319/001 ILARIS CANAKINUMAB INJECTABLE/ SUBCUTANEOUS 180MG

Manufacturers

Manufacturer name
Novartis Pharmaceuticals UK Ltd

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved